91 results
8-K
EX-99.1
RYTM
Rhythm Pharmaceuticals Inc.
22 Feb 24
Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business Update
7:01am
--
-- Spain and Italy authorities approve reimbursement for IMCIVREE to treat patients with Bardet-Biedl syndrome –
-- Acquired global rights to oral … and that the Company has received payor approval for reimbursement for 70 prescriptions during the fourth quarter of 2023.
On February 7, 2024
8-K
j03peklig
4 Jan 24
Entry into a Material Definitive Agreement
7:00am
8-K
EX-3.1
noe e2f4d3j
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:16pm
8-K
hriwr5v
6 Dec 23
Other Events
4:30pm
8-K
EX-99.1
0mzzmu 4ifr
7 Nov 23
Rhythm Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Update
7:05am
8-K
p9snr0kfn
21 Aug 23
Other Events
4:30pm
8-K
EX-10.1
aray8
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.2
0a8ngx2boj65lghd
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
5qtx52s
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.4
g98xj2j60mq9ll3m
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-10.3
tyj6oc
3 Aug 23
Departure of Directors or Certain Officers
5:22pm
8-K
EX-99.1
fx3nwu8230
1 Aug 23
Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business
7:05am
8-K
EX-99.1
m5i8 1ygdgcqtx5wwjq9
2 May 23
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
7:05am